Patient Recruitment Featured Articles

1. Building Patient Trust In Research Through Connection Driven-Transparency 2/4/2026

   The question is not whether trust matters but how industry, sponsors, and investigators can bridge the trust gap to drive patient participation.

2. Patient Trust In Pharma Is Low; Here's How To Rebuild It 2/2/2026

   CISCRP's Annick de Bruin and Shalome Sine provide strategies for building patient trust based on the findings from their Perceptions & Insights Study.

3. The U.S. Trial Advantage Is Eroding 1/30/2026

   Once the go-to location for trials, the U.S. is now seeing competition from APAC, driven by political, economic, and workforce pressures domestically and rapid growth abroad.

4. Will New AI Health Assistants Suggest Clinical Trials To Inquiring Patients? 1/27/2026

   New AI health assistants are now doing even more to help patients make sense of symptoms, diagnoses, and treatment options. What does that mean for the discoverability of clinical trials?

5. How Gilead Includes Patients Most Affected By HIV In Its PrEP Trials 1/26/2026

   VP of Clinical Development, HIV, Moupali Das shares how the sponsor approaches diverse participant recruitment and enrollment, highlighting the importance of early demographic research and careful, intentional PI selection.

6. When Clinical Trials Don't Stop For War 1/23/2026

   When war halted clinical trials in Ukraine, sites adapted instead of shutting down. Dr. Anna Titkova explains how patients, investigators, and sponsors kept research moving when conditions were anything but stable.

7. "Study Within A Study" Reveals Best Recruitment Strategies For Alzheimer's Trials 1/20/2026

   In this Q&A, Acumen Pharmaceuticals shares findings from its Alzheimer's recruitment study, highlighting what efforts proved the most fruitful.

8. Endpoints, Procedures, And Deviations Are On The Rise — Why? 1/20/2026

   SCRS Chief Site Success Officer Jimmy Bechtel, MBA, and Tufts CSDD Executive Director Ken Getz, MBA, discuss why they're on the rise explore ways to address, and even accept, them. 

9. Confronting "Time Toxicity" In Global Oncology And Rare Disease Trials For Operational Excellence And Patient Retention 1/14/2026

   Time is the only truly finite resource in a clinical trial. Consultant Leila Cupersmith discusses how sponsors can better design trials with a lower time burden to boost enrollment, retention, and overall operational excellence.

10. The Case For Research-Naive PIs 1/9/2026

    Carrie Lewis, executive director, clinical program optimization, at Keenova (formerly Endo) explains why research-naive PIs may improve trial quality, challenge assumptions about ROI, and help fix a shrinking investigator pipeline.